Design of P1′ and P3′ residues of trivalent thrombin inhibitors and their crystal structures

被引:13
|
作者
Sion-Usakiewicz, JJ [1 ]
Sivaraman, J [1 ]
Li, YG [1 ]
Cygler, M [1 ]
Konishi, Y [1 ]
机构
[1] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
关键词
D O I
10.1021/bi992419b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic bivalent thrombin inhibitors comprise an active site blocking segment, a fibrinogen recognition exosite blocking segment, and a linker connecting these segments. Possible nonpolar interactions of the P1' and P3' residues of the linker with thrombin S1' and S3' subsites, respectively, were identified using the "Methyl Scan" method [Slon-Usakiewicz et al. (1997) Biochemistry 36, 13494-13502]. A series of inhibitors (4-tert-butylbenzenesulfonyl)-Arg-(D-pipecolic acid)-Xaa-Gly-Yaa-Gly-beta Ala-Asp-Tyr-Glu-Pro-Ile-Pro-Glu-Glu-Ala-(beta-cyclohexylalanine in which nonpolar P1' residue Xaa or P3' residue Yaa was incorporated, were designed and improved the affinity to thrombin. Substitution of the P3' residue with D-phenylglycine or D-Phe improved the K-i value to (9.5 +/- 0.6) x 10(-14) or 1.3 +/- 0.5 x 10(-13) M, respectively, compared to that of a reference inhibitor with Gly residues at Xaa and Yaa residues (K-i = (2.4 +/- 0.5) x 10(-11) M). Similarly, substitution of the P1' residue with L-norleucine or L-beta-(2-thienyl)alanine lowered the K-i values to (8.2 +/- 0.6) x 10-14 or(5.1 +/- 0.4) x 10(-14) M, respectively. The linker Gly-Gly-Gly-beta Ala of the inhibitors in the previous sentence was simplified with 12-aminododecanoic acid, resulting in further improvment of the K-i values to (3.8 +/- 0.6) x 10(-14) or (1.7 +/- 0.4) x 10(-14) M, respectively. These K-i values are equivalent to that of natural hirudin (2.2 x 10(-14) M), yet the size of the synthetic inhibitors (2 kD) is only one-third that of hirudin (7 kD). Two inhibitors, with L-norleucine or L-beta-(2-thienyl)alanine at the P1' residue and the improved linker of 12-aminododecanoic acid, were crystallized in complex with human alpha-thrombin. The crystal structures of these complexes were solved and refined to 2.1 Angstrom resolution. The Lys(60F) Side chain of thrombin moved significantly and formed a large nonpolar S1' subsite to accommodate the bulky P1' residue.
引用
收藏
页码:2384 / 2391
页数:8
相关论文
共 50 条
  • [31] Novel acylguanidine containing thrombin inhibitors with reduced basicity at the P1 moiety
    Adang, AEP
    Lucas, H
    de Man, APA
    Engh, RA
    Grootenhuis, PDJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3603 - 3608
  • [32] Azaindoles: Moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors
    Sanderson, PEJ
    Stanton, MG
    Dorsey, BD
    Lyle, TA
    McDonough, C
    Sanders, WM
    Savage, KL
    Naylor-Olsen, AM
    Krueger, JA
    Lewis, SD
    Lucas, BJ
    Lynch, JJ
    Yan, YW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) : 795 - 798
  • [33] EFFECTS OF CRYSTALLINE STRUCTURE ON PEAKS P1 P2 AND P3 MEASURED BY A TORSION CLOCK
    BAYS, B
    BENOIT, W
    GRANDCHAMP, PA
    HELVETICA PHYSICA ACTA, 1968, 41 (04): : 422 - +
  • [34] Resistance in plants transformed with the P1 or P3 gene of tobacco vein mottling potyvirus
    Moreno, M
    Bernal, JJ
    Jiménez, I
    Rodríguez-Cerezo, E
    JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 2819 - 2827
  • [35] P1 AND P1' MODIFIED PHOSPHINIC DIPEPTIDE ANALOGUE INHIBITORS OF METALLOAMINOPEPTIDASES
    Talma, M.
    Weglarz-Tomczak, E.
    Staszewska, K.
    Mucha, A.
    JOURNAL OF PEPTIDE SCIENCE, 2016, 22 : S184 - S184
  • [36] PEPTIDE BOROISOTHIOURONIUM COMPOUNDS AS INHIBITORS OF THROMBIN - A SPECIFICITY STUDY ACCORDING TO THE P3 RESIDUE
    GOODWIN, C
    SCULLY, MF
    DEADMAN, J
    CHINO, N
    ELGENDY, S
    KAKKAR, VV
    CLAESON, G
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 667 - 667
  • [37] Design and synthesis of ß-Secretase inhibitors:: Optimization at the P4 and P1' positions
    Hamada, Yoshio
    Shuto, Daisuke
    Igawa, Naoto
    Kasai, Soko
    Liu, Ping
    Hidaka, Koushi
    Kimura, Tooru
    Hayashi, Yoshio
    Ishiura, Shoichi
    Kiso, Yoshiaki
    Understanding Biology Using Peptides, 2006, : 599 - 600
  • [38] Design and synthesis of β-secretase inhibitors:: Optimization at the P4 and P1' positions
    Hamada, Y
    Shuto, D
    Igawa, N
    Kasai, S
    Liu, P
    Hidaka, K
    Kimura, T
    Hayashi, Y
    Ishiura, S
    Kiso, Y
    BIOPOLYMERS, 2005, 80 (04) : 580 - 580
  • [39] HEPATITIS-A VIRUS PROTEINASE 3C CLEAVES INTERMOLECULARLY IN P1, P2 AND P3
    SCHULTHEISS, T
    KUSOV, Y
    GAUSSMULLER, V
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 13 - 13
  • [40] STRUCTURE-FUNCTION ASPECTS OF NEUTRAL P1 RESIDUE PEPTIDE INHIBITORS OF THROMBIN
    DEADMAN, J
    CLAESON, G
    SCULLY, MF
    JOURNAL OF ENZYME INHIBITION, 1995, 9 (01): : 29 - 41